Today, analysts at Oppenheimer highlight their views on the technology giant Apple Inc. (NASDAQ:AAPL), Chinese e-commerce giant Alibaba Group Holding Ltd (NYSE:BABA) …
Gilead Sciences, Inc. (NASDAQ:GILD) announced today its results of operations for the third quarter ended September 30, 2015.
Analysts and investors have a lot to look forward to this week as earnings season rolls on. Here’s what you need to know …
J.P.
Analysts are weighing in on the pharmaceutical giant Gilead Sciences, Inc. (NASDA:GILD) and Cambridge biotechnology giant Biogen Inc (NASDAQ:BIIB), with mixed ratings and views.
Gilead Sciences, Inc. (NASDAQ:GILD) confirmed that the company fulfilled a request for compassionate access to GS-5734, a novel nucleotide analogue in development for …
Gilead Sciences, Inc. (NASDAQ:GILD) announced that the U.
In light of upcoming events in the biotechnology sector slated for the fourth quarter of this year, Needham analyst Alan Carr weighed in …
Israel Englander, a billionaire hedge fund manager, is the Chairman and CEO of Millennium Management. Let’s look at some of the recent moves …
Gilead Sciences, Inc. (NASDAQ:GILD) announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency …
